Event-Driven Stocks

Hinge Health, Inc.

HNGENYSE

Technology · Services-Computer Processing & Data Preparation · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs4 good2 warning1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23
Revenue$587.9M$390.4M$292.7M
Operating income−$546.4M−$31.9M−$130.5M
Net income−$528.3M−$11.9M−$108.1M
Total assets$744.8M$673.3M
Total liabilities$366.2M$256.6M
Equity$178.7M−$434.6M−$424.0M
EPS (diluted)$-7.77$-0.88$-8.31
Shares out.016.4M13.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−92.9%
Net margin
−89.9%
Return on equity
−295.7%
Return on assets
−70.9%
Return on capital (ROCE)
−142.9%
Liabilities / assets
49.2%
Debt / equity
2.05×
Book value / share
Revenue growth (YoY)
50.6%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-7.51distress
Accruals / assets
93.9%clean
Beneish M-Score
-6.40normal
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
62
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 severe2 warning4 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20264.2M1.8+2.5%
Apr 30, 20264.1M5.8+3.9%
Apr 15, 20264.0M5.8-5.6%
Mar 31, 20264.2M4.8+6.0%
Mar 13, 20264.0M3.0+2.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗
  • 4Jun 1, 2026
  • 144Jun 1, 2026
  • 144Jun 1, 2026
  • 4Jun 1, 2026
  • 4May 27, 2026
  • 4May 27, 2026
  • 4May 27, 2026
  • 144May 26, 2026
  • 144May 26, 2026
  • 4May 21, 2026
  • 144May 20, 2026
  • 4May 19, 2026
  • 4May 19, 2026
  • 4May 12, 2026
  • 4May 11, 2026

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.